Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricREGNRegeneron PharmaceuticalsVRTXVertex PharmaceuticalsBIIBBiogen
Snapshot
Price$612.50$466.79$199.71
Market cap$63.95B$115.02B$29.02B
Valuation
P/E14.4x26.3x21.1x
Forward P/E13.8x24.7x23x
Growth
Revenue growth5.9%10.1%1.2%
EPS growth4.4%6.1%-8.1%
Profitability
Net margin29.6%35.5%13.8%
ROE14.3%23.9%7.5%
Balance sheet & cash
Debt / equity0.09x0.01x0.34x
Free cash flow yield6.3%3.1%6.8%
Dividend yield0.6%——
Verdict
Investment ratingFavorable· 69Favorable· 67Neutral· 49

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearREGNtoday $613VRTXtoday $467BIIBtoday $200
2027$479.59 – $703.40+15% CAGR$371.52 – $544.89+17% CAGR$152.78 – $224.07+12% CAGR
2028$500.69 – $734.34+9% CAGR$394.26 – $578.24+11% CAGR$155.83 – $228.56+7% CAGR
2029$522.72 – $766.66+8% CAGR$418.38 – $613.63+10% CAGR$158.95 – $233.13+5% CAGR
2030$545.72 – $800.39+7% CAGR$443.99 – $651.18+9% CAGR$162.13 – $237.79+4% CAGR
2031$569.73 – $835.61+6% CAGR$471.16 – $691.04+8% CAGR$165.37 – $242.55+4% CAGR
5-yr CAGR-1.4% – 6.4%0.2% – 8.2%-3.7% – 4.0%